UBS Group’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-293,502
| Closed | -$41.1K | – | 9004 |
|
|
2024
Q1 | $41.1K | Buy |
293,502
+281,287
| +2,303% | +$39.4K | ﹤0.01% | 5432 |
|
|
2023
Q4 | $1.77K | Buy |
+12,215
| New | +$1.77K | ﹤0.01% | 7010 |
|
|
2023
Q3 | – | Sell |
-8,368
| Closed | -$26.1K | – | 8849 |
|
|
2023
Q2 | $26.1K | Buy |
+8,368
| New | +$26.1K | ﹤0.01% | 5692 |
|
|
2022
Q2 | – | Sell |
-6,200
| Closed | -$15K | – | 9958 |
|
|
2022
Q1 | $15K | Buy |
6,200
+122
| +2% | +$295 | ﹤0.01% | 6819 |
|
|
2021
Q4 | $28K | Buy |
+6,078
| New | +$28K | ﹤0.01% | 6356 |
|
|
2021
Q3 | – | Sell |
-284
| Closed | -$3K | – | 8933 |
|
|
2021
Q2 | $3K | Sell |
284
-4,065
| -93% | -$42.9K | ﹤0.01% | 7748 |
|
|
2021
Q1 | $38K | Buy |
4,349
+2,393
| +122% | +$20.9K | ﹤0.01% | 5798 |
|
|
2020
Q4 | $20K | Buy |
1,956
+1,162
| +146% | +$11.9K | ﹤0.01% | 5945 |
|
|
2020
Q3 | $7K | Sell |
794
-2,110
| -73% | -$18.6K | ﹤0.01% | 6273 |
|
|
2020
Q2 | $21K | Buy |
2,904
+1,899
| +189% | +$13.7K | ﹤0.01% | 5687 |
|
|
2020
Q1 | $10K | Sell |
1,005
-2,384
| -70% | -$23.7K | ﹤0.01% | 6031 |
|
|
2019
Q4 | $45K | Buy |
+3,389
| New | +$45K | ﹤0.01% | 5365 |
|